CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
Joel Simrén(University of Gothenburg), Kaj Blennow(Sahlgrenska University Hospital), Nicholas J. Ashton(King's College London), Wagner S. Brum(Universidade Federal do Rio Grande do Sul), Hlin Kvartsberg(University of Gothenburg), Vanessa Pallen(McGill University), Andréa Lessa Benedet(University of Pittsburgh), Thomas K. Karikari(University of Pittsburgh), Firoza Z Lussier(McGill University), Keqiang Ye(Shenzhen University Health Science Center), Emma Sjons(Sahlgrenska University Hospital), Robert Hopewell(Montreal Neurological Institute and Hospital), Henrik Zetterberg(University of Wisconsin–Madison), Pedro Rosa‐Neto(Center for Diagnosis and Research on Alzheimer's Disease), Tharick A. Pascoal(Montreal Neurological Institute and Hospital), Jenna Stevenson(McGill University), Mira Chamoun(Douglas Mental Health University Institute)
Cited by 33
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k